JNJ vs MRK: stock comparison and AI forecast
Johnson & Johnson (JNJ) and Merck & Co., Inc. (MRK) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
JNJ Johnson & Johnson
- Price
- $276.22 +24.1% · 6M
- Market Cap
- $664.95B
- P/E Ratio
- 42.0x
- Size
- mega-cap
- AI Forecast
MRK Merck & Co., Inc.
- Price
- $146.73 +30.7% · 6M
- Market Cap
- $362.01B
- P/E Ratio
- 151.3x
- Size
- mega-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- JNJ is 1.8 times larger than MRK by market capitalization ($664.95B against $362.01B).
- JNJ trades at 42.0 times trailing earnings, MRK at 151.3 times.
- Over the last six months MRK returned +30.7% and JNJ +24.1%.
- JNJ turns 16.2% of its revenue into net income, against 3.6% for MRK.
- MRK carries 1.96 times debt per unit of equity, against 1.42 times for JNJ.
- MRK yields 2.31% in dividends and JNJ 1.91%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | JNJ | MRK |
|---|---|---|
| Market Cap | $664.95B | $362.01B |
| P/E Ratio | 41.98x | 151.27x |
| P/B Ratio | 8.16x | 8.06x |
| Dividend Yield | 1.91% | 2.31% |
| EPS | $6.58 | $0.97 |
| Book Value/Share | $33.87 | $18.20 |
| Revenue/Share | $41.26 | $27.31 |
| FCF/Share | $8.55 | $5.98 |
Profitability & Margins
| Metric | JNJ | MRK |
|---|---|---|
| ROE | 19.7% | 5.5% |
| ROA | 8.2% | 1.9% |
| Gross Margin | 67.6% | 71.8% |
| Net Margin | 16.2% | 3.6% |
| EBT Margin | 17.9% | 7.1% |
| Tax Rate | 9.3% | 48.5% |
Financial Health
| Metric | JNJ | MRK |
|---|---|---|
| Current Ratio | 1.02x | 1.35x |
| Quick Ratio | 0.74x | 1.14x |
| D/E Ratio | 1.42x | 1.96x |
| Financial Leverage | 2.42x | 2.96x |
| Interest Coverage | 42.2x | – |
| Working Capital | $894M | $10.14B |
Cash Flow
| Metric | JNJ | MRK |
|---|---|---|
| Operating Cash Flow | $26.16B | $18.70B |
| Free Cash Flow | $20.59B | $14.75B |
| Capital Spending | -$5.57B | -$3.96B |
| OCF Growth YoY | 8.1% | 9.6% |
| FCF Growth YoY | 5.1% | 13.0% |
| FCF/Sales | 20.7% | 21.9% |
| CapEx/Sales | 5.6% | 5.9% |
Operational Efficiency
| Metric | JNJ | MRK |
|---|---|---|
| Asset Turnover | 0.50x | 0.51x |
| Receivables Turnover | 5.2x | 5.3x |
| Inventory Turnover | 2.1x | 3.1x |
| Fixed Assets Turnover | 4.1x | 2.6x |
| Days Sales Outstanding | 70 days | 69 days |
| Days Inventory | 174 days | 118 days |
| Payables Period | 106 days | 96 days |
| Cash Conversion Cycle | 138 days | 91 days |
Income Statement
| Metric | JNJ | MRK |
|---|---|---|
| Total Revenue | $99.33B | $67.38B |
| Net Income | $16.09B | $2.45B |
| R&D Expense | $1.53B | $30.76B |
| SG&A Expense | $25.50B | $11.39B |
| Cost of Goods Sold | $32.22B | $19.03B |
Dividend & Shareholder Information
| Metric | JNJ | MRK |
|---|---|---|
| Dividends Per Share | $5.28 | $3.39 |
| Payout Ratio | 80.2% | 349.5% |
| Shares Outstanding | 2407M | 2467M |
| Net Income Growth | -35.9% | -87.1% |
| EPS Growth | -36.5% | -87.2% |
JNJ vs MRK: stock comparison and AI forecast
Which is bigger, JNJ or MRK?
JNJ is 1.8 times larger than MRK by market capitalization ($664.95B against $362.01B).
Which is cheaper on earnings, JNJ or MRK?
JNJ trades at 42.0 times trailing earnings, MRK at 151.3 times.
Which stock performed better over the last six months, JNJ or MRK?
Over the last six months MRK returned +30.7% and JNJ +24.1%.
Which one does Intratio's AI model rank higher, JNJ or MRK?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.